Fertility, Hypercoagulability, and Inflammation (FREYA) Registry

Active, not recruitingOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions

Thrombophilia

Interventions

OTHER

No intervention

Trial Locations (1)

Brigham and Women's Hospital, Boston

All Listed Sponsors

lead

Brigham and Women's Hospital

OTHER

NCT04537416 - Fertility, Hypercoagulability, and Inflammation (FREYA) Registry | Biotech Hunter | Biotech Hunter